104 related articles for article (PubMed ID: 16373262)
1. Drug-eluting versus third-generation bare metal stents: the US strategy.
Isenbarger DW; Resar JR
Int J Cardiovasc Intervent; 2005; 7(4):171-5. PubMed ID: 16373262
[TBL] [Abstract][Full Text] [Related]
2. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death.
Applegate RJ; Sacrinty MT; Kutcher MA; Baki TT; Gandhi SK; Santos RM; Little WC
Am J Cardiol; 2007 Feb; 99(3):333-8. PubMed ID: 17261393
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?
Ryan J; Cohen DJ; Pinto DS
Coron Artery Dis; 2006 Dec; 17(8):667-71. PubMed ID: 17119374
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts.
Okabe T; Lindsay J; Buch AN; Steinberg DH; Roy P; Slottow TL; Smith K; Torguson R; Xue Z; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R
Am J Cardiol; 2008 Sep; 102(5):530-4. PubMed ID: 18721507
[TBL] [Abstract][Full Text] [Related]
6. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
7. Still a future for the bare metal stent?
Barlis P; Di Mario C
Int J Cardiol; 2007 Sep; 121(1):1-3. PubMed ID: 17360051
[TBL] [Abstract][Full Text] [Related]
8. Benefits of drug-eluting stents in coronary heart disease treatment with emphasis on the diabetic subgroup.
Nguyen MC; Lim YL
Heart Lung Circ; 2007 Feb; 16(1):7-9. PubMed ID: 17169611
[No Abstract] [Full Text] [Related]
9. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Ray GM; Nawarskas JJ; Frishman WH
Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
[TBL] [Abstract][Full Text] [Related]
10. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
Yan BP; Duffy SJ; Clark DJ; Lefkovits J; Warren R; Gurvitch R; Lew R; Sebastian M; Brennan A; Andrianopoulos N; Reid CM; Ajani AE;
Am J Cardiol; 2008 Jun; 101(12):1716-22. PubMed ID: 18549846
[TBL] [Abstract][Full Text] [Related]
11. Drug eluting stents for everyone and everything?
Laham RJ
Catheter Cardiovasc Interv; 2005 Dec; 66(4):512-3. PubMed ID: 16270362
[No Abstract] [Full Text] [Related]
12. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.
Roukoz H; Bavry AA; Sarkees ML; Mood GR; Kumbhani DJ; Rabbat MG; Bhatt DL
Am J Med; 2009 Jun; 122(6):581.e1-10. PubMed ID: 19486720
[TBL] [Abstract][Full Text] [Related]
14. From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents.
Thanigaraj S; Wollmuth JR; Zajarias A; Chemmalakuzhy J; Lasala JM
Coron Artery Dis; 2006 Dec; 17(8):673-9. PubMed ID: 17119375
[TBL] [Abstract][Full Text] [Related]
15. Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program.
Ryan J; Linde-Zwirble W; Engelhart L; Cooper L; Cohen DJ
Circulation; 2009 Feb; 119(7):952-61. PubMed ID: 19204307
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
17. New drug-eluting stent platforms to prevent stent thrombosis.
Kereiakes DJ
Rev Cardiovasc Med; 2007; 8 Suppl 1():S34-43. PubMed ID: 17401310
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stent era: will we improve 5-year outcomes?
Cutlip DE
Coron Artery Dis; 2006 Dec; 17(8):681-4. PubMed ID: 17119376
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI).
Escolar E; Mintz GS; Popma J; Michalek A; Kim SW; Mandinov L; Koglin J; Stone G; Ellis SG; Grube E; Dawkins KD; Weissman NJ
Am J Cardiol; 2007 Aug; 100(4):621-6. PubMed ID: 17697817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
